医学
止血
随机对照试验
外科
上消化道出血
内窥镜检查
作者
Paola Soriani,Paolo Biancheri,Giuliano Francesco Bonura,Tommaso Gabbani,Enrique Rodríguez de Santiago,Lorenzo Dioscoridi,Gianluca Andrisani,Carmelo Luigiano,S. Deiana,J. Rainer,Mariagrazia Del Buono,Rocco Amendolara,Massimiliano Marino,Cesare Hassan,Alessandro Repici,Mauro Manno
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2024-04-10
卷期号:56 (09): 665-673
被引量:8
摘要
Abstract Background First-line over-the-scope (OTS) clip treatment has shown higher efficacy than standard endoscopic therapy in acute nonvariceal upper gastrointestinal bleeding (NVUGIB) from different causes. We compared OTS clips with through-the-scope (TTS) clips as first-line mechanical treatment in the specific setting of peptic ulcer bleeding. Methods We conducted an international, multicenter randomized controlled trial on consecutive patients with suspected NVUGIB. Patients with Forrest Ia–IIb gastroduodenal peptic ulcer were randomized 1:1 to OTS clip or TTS clip treatment. The primary outcome was the rate of 30-day rebleeding after successful initial hemostasis. Secondary outcomes included the rates of successful initial hemostasis and overall clinical success, defined as the composite of successful initial hemostasis and no evidence of 30-day rebleeding. Results 251 patients were screened and 112 patients were randomized to OTS (n = 61) or TTS (n = 51) clip treatment. The 30-day rebleeding rates were 1.6% (1/61) and 3.9% (2/51) in patients treated with OTS clips and TTS clips, respectively (Kaplan–Meier log-rank, P = 0.46). Successful initial hemostasis rates were 98.4% (60/61) in the OTS clip group and 78.4% (40/51) in the TTS clip group (P = 0.001). Overall clinical success rates were 96.7% (59/61) with OTS clips and 74.5% (38/51) with TTS clips (P = 0.001). Conclusions Low rates of 30-day rebleeding were observed after first-line endoscopic treatment of acute peptic ulcer bleeding with either OTS or TTS clips. However, OTS clips showed higher efficacy than TTS clips in achieving successful initial hemostasis and overall clinical success.
科研通智能强力驱动
Strongly Powered by AbleSci AI